Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by made2laston Dec 14, 2016 9:40pm

139 Views

Post# 25602018

RE:RE:Front Line Treatment

Hi vestor111;

Perhaps these doctors are multitudes smarter than all of us put togather.

Do you remember the angst a week or two back over using 1433 without incubating it in transferrin?

Well, just maybe, scrapping the interior of the bladder first will remove some of the offending cancer cells and cause just enough bleeding in the bladder to allow the 1433 to pick up a load of transferrin and launch theirselves right into the cancer cells.

Zap the interior of the bladder with a bit of the right wavelength of light, and presto, whamo, goodbye cancer cells.

Thanks;

made2last

Bullboard Posts

Rig Count Soars as Utilization Surpasses Industry Averages